Slow Bull
The market, slowly. THURSDAY, 24 SEPTEMBER 2026
← All news
Markets

TScan Therapeutics, Inc. (TCRX) Discusses Strategic Refocus on In Vivo Cell Therapy for Solid Tumors and Pausing of Phase III Heme Study Transcript

1 source ·1 article ·Sep 2, 16:14 UTC TScan Therapeutics Information Services

Covered by 1 outlet

Seekingalpha 1

All coverage · 1 article

Seeking Alpha ·Sep 2, 16:14 UTC

TScan Therapeutics, Inc. (TCRX) Discusses Strategic Refocus on In Vivo Cell Therapy for Solid Tumors and Pausing of Phase III Heme Study Transcript